Every year my dated academic planners stress me out because I have to sell them before the school year is over. This time I got so busy with tradeshows that I completely forgot to check how many were ...

Earlier this week, Johnson & Johnson reported fourth-quarter 2025 sales of US$24,564 million and full-year sales of US$94,193 million, alongside issuing 2026 guidance that targets operational sales of ...

The healthcare giant forecast operational sales between $99.5 billion and $100.5 billion, above Wall Street's $98.9 billion estimate, and earnings of $11.43 to $11.63 per share. CFO Joseph Wolk said ...

KANSAS CITY, Mo. — Johnson County, Kansas commissioners agree to consider repealing a sales tax ballot question from the March 3 mail-in ballot after a state judge found the measure unlawful. Johnson ...

EXCLUSIVE: Trudy Blue, starring Dakota Johnson and directed by Angus MacLane, is kicking off sales at the American Film Market. Penned by Evan Twohy, Trudy Blue is a grounded sci-fi action movie set ...

Johnson Controls continues to see accelerating sales growth driven largely by demand for the company’s data center technologies. The company, which has its operating headquarters in Glendale, reported ...

Winnebago does not see sales for recreational vehicles getting any better this year, but it is seeing some positive momentum in the leisure market as a whole. The Eden Prairie-based company sells ...

Stickers are cut and ready for voters to take after they’ve submitted their ballots during early voting at the Iowa Memorial Union in Iowa City on Oct. 22, 2024. (Jim Slosiarek/The Gazette) Buy Photo ...

(RTTNews) - Drug major Johnson & Johnson (JNJ) Tuesday reported significantly higher profit in its third quarter with growth in sales. Both adjusted earnings and top line beat market estimates.

Johnson & Johnson (NYSE:JNJ) on Tuesday reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating the consensus of $2.75. The pharmaceutical and medtech ...

J&J lifts full-year sales guidance to as much as $93.9 billion, topping Wall Street forecasts. Orthopedics unit DePuy Synthes to be spun off within 24 months. Strong oncology and immunology sales ...

Johnson and Johnson is a buy as executives project strong medicine sales over the next two years and as the company expands its drugmaking operations in the U.S., according to Wells Fargo. The bank ...